2023-09-21T08:51:04-05:00 2022-12-31 221732349 WISS & COMPANY LLP 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 990 2022-01-01 133045282 AMERICAN FEDERATION FOR AGING RESEARCH INC AMER 2127039977 55 WEST 39TH STREET 16TH FLOOR NEW YORK NY 10018 STEPHANIE LEDERMAN EXECUTIVE DIRECTOR 2127039977 2023-09-20 1 STEPHANIE LEDERMAN XXX-XX-XXXX 0 DIANA MILLER P01597612 9739949400 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z STEPHANIE LEDERMAN 55 WEST 39TH STREET 16TH FLOOR NEW YORK NY 10018 18338810 0 X WWW.AFAR.ORG X 1980 NY ENHANCE THE QUALITY OF LIFE AND ALLEVIATE SUFFERING BY SUPPORTING BIOMEDICAL RESEARCH ON AGING. 36 35 11 325 0 0 12473680 14714391 0 0 1304602 412743 3500 0 13781782 15127134 5098619 12333806 0 0 1797002 2249821 0 0 358020 781485 1675908 7677106 16259535 6104676 -1132401 30014800 33818934 2905287 10668833 27109513 23150101 X THE AMERICAN FEDERATION FOR AGING RESEARCH ("AFAR") IS COMMITTED TOSUPPORTING THE SCIENCE OF HEALTHIER AGING. AFAR SUPPORTS NEW ANDEARLY-CAREER SCIENTISTS WHOSE RESEARCH EXPLORES THE BIOLOGY OF HOWPEOPLE AGE AND THE BIOLOGICAL CHANGES THAT CAUSE AGE-RELATED DISEASE.AFAR IDENTIFIES AND FUNDS A BROAD RANGE OF CUTTING-EDGE RESEARCH THAT IS MOST LIKELY TO INCREASE THE BODY OF KNOWLEDGE ON THE BIOLOGY OF AGING AND LEAD TO SIGNIFICANT MEDICAL BREAKTHROUGHS IN PREVENTING AND TREATING DISEASE AND INCREASING A HEALTHY LIFESPAN.IN ADDITION, AFAR ADDRESSES THE CRITICAL SHORTAGE OF PHYSICIANS WHO ARE ADEQUATELY TRAINED TO TAKE CARE OF AN AGING SOCIETY BY COLLABORATING WITH FOUNDATIONS, CORPORATIONS AND INDIVIDUALS TO OFFER UNIQUE GRANT OPPORTUNITIES. 0 0 15217309 12333806 SCIENTIFIC PROGRAMS:AWARDS FOR BIOMEDICAL RESEARCH INTO AGING. IN 2022 AFAR AWARDED $12,333,806 TO 83 RESEARCHERS AND RESEARCH CENTERS.CREATING OPPORTUNITIES FOR SCIENTISTS AND CLINICIANS TO SHARE KNOWLEDGE AND EXCHANGE IDEAS TO ENCOURAGE INNOVATIVE THINKING AND COLLABORATIONS. IN 2022 AFAR CONDUCTED 3 CONFERENCES THAT CONNECTED RESEARCHERS ACROSS THE COUNTRY. 15217309 1 1 0 0 0 0 0 0 0 1 1 1 0 1 1 1 1 0 0 0 0 1 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 35 0 1 11 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 X 36 35 1 0 1 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 NY X X X FREDERICA BLUM 3475592187 55 WEST 39TH STREET 16TH FLOOR NEW YORK NY 10018 STEPHANIE LEDERMAN EXECUTIVE DIRECTOR 37.50 X 607952 0 73514 ODETTE S VAN DER WILLIK DEPUTY EXECUTIVE DIRECTOR 37.50 X 235904 0 58202 FREDERICA L BLUM FINANCE DIRECTOR 37.50 X 177841 0 34968 JOHN A CHAICH PUBLIC RELATIONS DIRECTOR 37.50 X 153214 0 32608 CATHERINE A CULLAR ADMINISTRATIVE MANAGER 37.50 X 115077 0 28702 HATTIE HERMAN PROGRAM OFFICER 37.50 X 112721 0 28752 STEVEN N AUSTAD PHD INTERIM BOARD CHAIR 10.00 X X 42000 0 0 HARVEY JAY COHEN MD DIRECTOR 2.00 X 1000 0 0 ANN M CONNOLLY CHAIR 4.00 X X 0 0 0 LAURA BARZILAI VICE CHAIR 2.00 X X 0 0 0 JAMES L KIRKLAND MD PHD PRESIDENT 4.00 X X 0 0 0 MARK S LACHS MPH IMMEDIATE PAST PRESIDENT 4.00 X X 0 0 0 CHARLES BEEVER TREASURER/SECRETARY 4.00 X X 0 0 0 NIR BARZILAI SCIENTIFIC DIRECTOR 4.00 X X 0 0 0 ALEXANDRA L GATJE DIRECTOR 2.00 X 0 0 0 ANA MARIE CUERVO MD PHD DIRECTOR 2.00 X 0 0 0 ANNAROSA MIELE DIRECTOR 2.00 X 0 0 0 CAROLINE S BLAUM MD DIRECTOR 2.00 X 0 0 0 DAVID A SINCLAIR PHD AO DIRECTOR 2.00 X 0 0 0 DAVID L EIGEN DIRECTOR 2.00 X 0 0 0 DENISE LEFEBVRE DIRECTOR 2.00 X 0 0 0 JIM MELLON DIRECTOR 2.00 X 0 0 0 JOYCE M YAEGER DIRECTOR 2.00 X 0 0 0 KEITH WHITFIELD DIRECTOR 2.00 X 0 0 0 KENNETH BUCKFIRE DIRECTOR 2.00 X 0 0 0 KEVIN J LEE PHD DIRECTOR 2.00 X 0 0 0 LAURA NIEDERNHOFER MD PHD DIRECTOR 2.00 X 0 0 0 MARK R COLLINS DIRECTOR 2.00 X 0 0 0 MEHMOOD KHAN OUTGOING DIRECTOR 10/2022 2.00 X 0 0 0 MICHAEL W HODIN PHD DIRECTOR 2.00 X 0 0 0 NATHANIEL E DAVID PHD DIRECTOR 2.00 X 0 0 0 NIGEL F EMMETT DIRECTOR 2.00 X 0 0 0 NORMAN VOLK DIRECTOR 2.00 X 0 0 0 PETER KIMMELMAN DIRECTOR 2.00 X 0 0 0 POL VANDENBROUCKE MD DIRECTOR 2.00 X 0 0 0 RICHARD BESDINE MD DIRECTOR 2.00 X 0 0 0 RICHARD GA FARAGHER DIRECTOR 2.00 X 0 0 0 S JAY OLSHANSKY PHD DIRECTOR 2.00 X 0 0 0 SAMI SAGOL DIRECTOR 2.00 X 0 0 0 SERGEY YOUNG DIRECTOR 2.00 X 0 0 0 TERRIE FOX WETLE PHD DIRECTOR 2.00 X 0 0 0 THOMAS A RANDO MD PHD DIRECTOR 2.00 X 0 0 0 THOMAS G KAHN CFA DIRECTOR 2.00 X 0 0 0 1445709 0 256746 6 0 1 0 CORNERSTONE GOVERNMENT AFFAIRS INC 800 MAINE AVENUE SW 7TH FLOOR WASHINGTON DC 20024 CONSULTING IN GOVERNMENT RELATIONS 240000 1 953212 13761179 14714391 412546 412546 3211873 3211676 197 197 197 15127134 0 0 412743 9916050 9916050 49201 49201 2368555 2368555 723466 483182 144529 95755 1155155 768678 229701 156776 91721 63237 19073 9411 164330 113297 34172 16861 115149 79389 23945 11815 40000 10494 29506 38750 10166 28584 64260 64260 577111 554728 8153 14230 11057 11057 51133 29875 11984 9274 41023 26607 8127 6289 215513 144413 43254 27846 510840 493750 12614 4476 7208 7208 12265 12265 OTHER PROGRAM COSTS 77601 77601 DUES & FILING FEES 21356 12477 5005 3874 REPAIRS & MAINTENANCE 7791 4552 1826 1413 16259535 15217309 684206 358020 4876771 2157182 1421815 290583 6651070 13371824 66106 54836 38790 15803 17941 22987 15138769 15924001 1842328 1997521 30014800 33818934 210440 304939 2694847 9777327 0 586567 2905287 10668833 X 7247896 6203960 19861617 16946141 27109513 23150101 30014800 33818934 X -1132401 -2697547 -129464 X X 0 1 X 1 1 1 X 3096693 2436685 5582532 12473680 14714391 38303981 3096693 2436685 5582532 12473680 14714391 38303981 22597680 15706301 706190 238587 327112 820893 412546 2505328 20167 3500 23667 40832976 0.38460 0.38050 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS REVENUE - 2020 AMOUNT: $ 20,167. 2021 AMOUNT: $ 3,500. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 13669188 50000 -2336437 25407 11357344 12588672 50000 1814912 784396 13669188 11147577 1782265 341170 12588672 9509966 50000 1893037 305426 11147577 9925480 50000 -160088 305426 9509966 0.46439 0.38841 0.14720 0 0 30125 9738 20387 8665 6065 2600 22987 COMMON STOCKS 409986 F MUTUAL FUNDS 9251312 F U.S. TREASURY SECURITIES 6262703 F 15924001 SECURITY DEPOSIT 45517 BENEFICIAL INTEREST IN CHARITABLE REMAINDER TRUST 1367853 OPERATING LEASE RIGHT OF USE ASSET, NET 584151 1997521 OPERATING LEASE LIABILITY 586567 586567 X 11936369 -2697547 -428958 -3126505 15062874 64260 64260 15127134 15895781 0 15895781 64260 299494 363754 16259535 PART X, LINE 2: AFAR IS EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE ("IRC") AND HAS MADE NO PROVISION FOR FEDERAL OR STATE INCOME TAXES IN THE ACCOMPANYING FINANCIAL STATEMENTS. IN ADDITION, AFAR HAS BEEN DETERMINED BY THE INTERNAL REVENUE SERVICE ("IRS") NOT TO BE A "PRIVATE FOUNDATION" WITHIN THE MEANING OF SECTION 509(A) OF THE IRC. ALL SIGNIFICANT TAX POSITIONS HAVE BEEN CONSIDERED BY MANAGEMENT AND IT HAS BEEN DETERMINED THAT ALL TAX POSITIONS WOULD BE SUSTAINED UPON EXAMINATION BY TAXING AUTHORITIES. AFAR IS REQUIRED TO FILE FORM 990 (RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX) AND THE NEW YORK CHAR500 (ANNUAL FILING FOR CHARITABLE ORGANIZATIONS), WHICH ARE SUBJECT TO EXAMINATION BY THE IRS AND THE STATE OF NEW YORK, RESPECTIVELY, UP TO THREE YEARS FROM THE EXTENDED DUE DATE OF THE TAX RETURN. AFAR IS NO LONGER SUBJECT TO EXAMINATIONS BY THE IRS AND THE STATE OF NEW YORK FOR YEAR ENDS PRIOR TO DECEMBER 31, 2019. OTHER SIGNIFICANT TAX POSITIONS INCLUDE ITS DETERMINATION OF WHETHER ANY AMOUNTS ARE SUBJECT TO UNRELATED BUSINESS INCOME TAX ("UBIT"). MANAGEMENT HAS DETERMINED THAT AFAR HAD NO ACTIVITIES SUBJECT TO UBIT IN THE YEARS ENDED DECEMBER 31, 2022 OR 2021. PART XI, LINE 2D - OTHER ADJUSTMENTS: CHANGES IN BENEFICIAL INTEREST IN CHARITABLE REMAINDER TRUST -428,958. PART XII, LINE 4B - OTHER ADJUSTMENTS: GRANT REFUNDS AND WRITE OFF 299,494. 0 0 0 0 0 0 0 0 0 EUROPE (INCLUDING ICELAND & GREENLAND) SCIENTIFIC RESEARCH 374900 0 EUROPE (INCLUDING ICELAND & GREENLAND) SCIENTIFIC RESEARCH 375000 0 NORTH AMERICA SCIENTIFIC RESEARCH 374027 0 MIDDLE EAST AND NORTH AFRICA SCIENTIFIC RESEARCH 375000 0 EUROPE (INCLUDING ICELAND & GREENLAND) SCIENTIFIC RESEARCH 374628 0 EAST ASIA AND THE PACIFIC SCIENTIFIC RESEARCH 375000 0 MIDDLE EAST AND NORTH AFRICA SCIENTIFIC RESEARCH 40000 0 MIDDLE EAST AND NORTH AFRICA SCIENTIFIC RESEARCH 80000 0 8 8 0 0 0 0 0 0 PART III ACCOUNTING METHOD: 1 ALBERT EINSTEIN COLLEGE OF MEDICINE 1300 MORRIS PARK AVENUE BRONX NY 10461 830621846 501(C)(3) 674617 0 SCIENTIFIC RESEARCH BUCK INSTITUTE FOR RESEARCH ON AGING 8001 REDWOOD BLVD NOVATO CA 94945 943030609 501(C)(3) 750000 0 SCIENTIFIC RESEARCH DANA-FARBER CANCER INSTITUTE 450 BROOKLINE AVE BP 437 BOSTON MA 022155450 042263040 501(C)(3) 300000 0 SCIENTIFIC RESEARCH DARTMOUTH-HITCHCOCK CLINIC ONE MEDICAL CENTER DRIVE LEBANON NH 03756 222519596 501(C)(3) 55789 0 SCIENTIFIC RESEARCH GENERAL HOSPITAL CORPORATION PO BOX 3829 BOSTON MA 022414876 042697983 501(C)(3) 375000 0 SCIENTIFIC RESEARCH INDIANA UNIVERSITY 620 UNION DRIVE ROOM 518 INDIANAPOLIS IN 46266 356001673 501(C)(3) 158106 0 SCIENTIFIC RESEARCH JOHNS HOPKINS UNIVERSITY 5501 HOPKINS BAYVIEW CIRCLE BALTIMORE MD 21224 520595110 501(C)(3) 19930 0 SCIENTIFIC RESEARCH MASSACHUSETTS INSTITUTE OF TECHNOLOGY 77 MASSACHUSETTS AVE CAMBRIDGE MA 02139 042103594 501(C)(3) 300000 0 SCIENTIFIC RESEARCH MAYO CLINIC 200 FIRST STREE SW ROCHESTER MN 55905 416011702 501(C)(3) 435000 0 SCIENTIFIC RESEARCH NEW YORK UNIVERSITY SPONSORED PROGRAMS ADMINISTRATION PO BOX 5166 NEW YORK NY 10087 746000203 501(C)(3) 54000 0 SCIENTIFIC RESEARCH OHIO GAMMA CHAPTER OF THE PHI DELTA THETA FRATERNITY 010 CHUBB HALL PO BOX 960 ATHENS OH 45701 316402113 501(C)(7) 60000 0 SCIENTIFIC RESEARCH OKLAHOMA MEDICAL RESEARCH FOUNDATION 825 NE 13TH ST OKLAHOMA CITY OK 73104 730580274 501(C)(3) 185000 0 SCIENTIFIC RESEARCH ORENTREICH FOUNDATION FOR THE ADVANCEMENT OF SCIENCE 910 FIFTH AVENUE NEW YORK NY 10021 136154215 501(C)(3) 375000 0 SCIENTIFIC RESEARCH REGENTS OF THE UNIVERSITY CALIFORNIA AT SAN DIEGO 9500 GILMAN DRIVE LA JOLLA CA 92063 956006144 501(C)(3) 810000 0 SCIENTIFIC RESEARCH REGENTS OF UNIVERSITY OF MINNESOTA NW 5957 MINNEAPOLIS MN 55485 416007513 501(C)(3) 125000 0 SCIENTIFIC RESEARCH REGENTS UNIVERSITY CALIFORNIA LOS ANGELES 405 HILGARD AVE LOS ANGELES CA 90095 956006143 501(C)(3) 125000 0 SCIENTIFIC RESEARCH SCRIPPS RESEARCH INSTITUTE PO BOX 741745 LOS ANGELES CA 900741745 330435954 501(C)(3) 124999 0 SCIENTIFIC RESEARCH THE ALLIANCE FOR LONGEVITY INITIATIVES 910 17TH STREET STE 314 WASHINGTON DC 20006 862957258 501(C)(4) 10000 0 SCIENTIFIC RESEARCH THE AMERICAN GERIATRICS SOCIETY INC 40 FULTON STREET FLOOR 18 NEW YORK NY 10038 131950856 501(C)(3) 47175 0 SCIENTIFIC RESEARCH TRUSTEES OF BOSTON UNIVERSITY BU GRANTS RECEIVABLES PO BOX 28763 NEW YORK NY 100878763 042103547 501(C)(3) 1047887 0 SCIENTIFIC RESEARCH UNIVERSITY OF ARKANSAS PO BOX 1404 FAYETTEVILLE AR 72702 716003252 501(C)(3) 124854 0 SCIENTIFIC RESEARCH UNIVERSITY OF CALIFORNIA SAN FRANCISCO 1855 FOLSOM STREET SAN FRANCISCO CA 94143 946036493 501(C)(3) 124011 0 SCIENTIFIC RESEARCH UNIVERSITY OF CONNECTICUT HEALTH CENTER 263 FARMINGTON AVE FARMINGTON CT 06030 521725543 GOVERNMENT 439909 0 SCIENTIFIC RESEARCH UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION PO BOX 931113 CLEVELAND OH 44193 616033693 501(C)(3) 375000 0 SCIENTIFIC RESEARCH UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 450 WEST DRIVE CHAPEL HILL NC 27599 566001393 501(C)(3) 54000 0 SCIENTIFIC RESEARCH UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER 865 RESEARCH PARKWAY OKLAHOMA CITY OK 73126 731563627 GOVERNMENT 500000 0 SCIENTIFIC RESEARCH UNIVERSITY OF PITTSBURGH 500 ROSS ST 154-0455 PITTSBURGH PA 152620001 250965591 501(C)(3) 380000 0 SCIENTIFIC RESEARCH UNIVERSITY OF SOUTHERN CALIFORNIA 3500 S FIGUEROA ST SUITE 102 LOS ANGELES CA 900898001 951642394 501(C)(3) 319998 0 SCIENTIFIC RESEARCH UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER SAN ANTONIO 7703 FLOYD CURL DR MSC 7828 SAN ANTONIO TX 782293901 741586031 501(C)(3) 124842 0 SCIENTIFIC RESEARCH UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER OFFICE POST AWARD ADMINISTRATION DALLAS TX 75284 756002868 GOVERNMENT 435000 0 SCIENTIFIC RESEARCH UNIVERSITY OF WASHINGTON GRANT CONTRACT ACCOUNTING 12455 COLLECTIONS DRIVE CHICAGO IL 606930001 916001537 GOVERNMENT 56500 0 SCIENTIFIC RESEARCH UNIVERSITY OF WISCONSIN-MADISON 21 NORTH PARK STREET SUITE 6401 MADISON WI 53715 396006492 GOVERNMENT 499839 0 SCIENTIFIC RESEARCH WAKE FOREST UNIVERSITY HEALTH SCIENCES MEDICAL CENTER BLVD WINSTONSALEM NC 27157 223849199 501(C)(3) 375000 0 SCIENTIFIC RESEARCH YALE UNIVERSITY 38 HILLHOUSE AVENUE NEW HAVEN CT 06511 060646973 501(C)(3) 44594 0 SCIENTIFIC RESEARCH 38 2 SCHOLARSHIPS 6 18027 FELLOWSHIPS 2 5000 HONORARY AWARDS 3 15000 CONFERENCE SUPPORT 4 8395 OTHER ASSISTANCE 1 2779 PART I, LINE 2: AFAR PREPARES THE AWARD MATERIALS, CONSISTING OF AN AWARD LETTER, AGREEMENT TO ACCEPT CONDITIONS FORM, DISCLAIMER FORM, MEDIA GUIDELINES. ONCE ALL THE COMPLETED AWARD MATERIALS ARE RETURNED TO AFAR AND AFAR HAS RECEIVED INSTITUTIONAL REVIEW BOARD OR INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE APPROVAL DOCUMENTATION (IF ANIMAL AND/OR HUMAN SUBJECTS ARE USED IN THE PROJECT), THE FIRST INSTALLMENT OF THE AWARD IS MADE. FURTHER INSTALLMENTS ARE MADE UPON RECEIPT OF SATISFACTORY PROGRESS REPORTS. GRANTEES MAY REQUEST NO-COST EXTENSIONS AND BUDGET REVISIONS WHICH ARE SUBMITTED AND REVIEWED BY AFAR STAFF. IN CERTAIN SITUATIONS CONSULTATION FROM THE SCIENTIFIC DIRECTOR OR CHAIR OF THE RESEARCH COMMITTEE IS REQUESTED BEFORE A REQUEST IS APPROVED. UNEXPENDED FUNDS AT THE END OF THE GRANT PERIOD MUST BE RETURNED TO AFAR. PART I, LINE 2, ADDITIONAL INFORMATION: GRANTEES ARE REQUIRED TO SUBMIT INTERIM REPORTS IN ORDER TO RECEIVE SECOND PAYMENTS ON AWARDS, AS WELL AS SUBMIT FINAL REPORTS ON HOW THEIR PROJECT WENT AND THE GRANT FUNDS WERE SPENT. X X X X 0 0 0 0 0 0 0 0 0 STEPHANIE LEDERMAN EXECUTIVE DIRECTOR 607952 0 0 0 0 0 39500 0 34014 0 681466 0 0 0 ODETTE S VAN DER WILLIK DEPUTY EXECUTIVE DIRECTOR 235904 0 0 0 0 0 23678 0 34524 0 294106 0 0 0 FREDERICA L BLUM FINANCE DIRECTOR 177841 0 0 0 0 0 18095 0 16873 0 212809 0 0 0 JOHN A CHAICH PUBLIC RELATIONS DIRECTOR 153214 0 0 0 0 0 15375 0 17233 0 185822 0 0 0 PART II: IN 2022, AFAR'S EXECUTIVE DIRECTOR, STEPHANIE LEDERMAN, RECEIVED A ONE-TIME LUMP SUM PAYMENT IN THE AMOUNT OF $210,367 IN SETTLEMENT OF LAPSED RETIREMENT BENEFITS. FORM 990, PART I, LINE 8, LINE 19 AND LINE 22: MOST OF AFAR'S FUNDING COMES FROM LARGE, RESTRICTED MULTI-YEAR CONTRIBUTIONS. IN YEARS WHEN NO NEW MULTI-YEAR CONTRIBUTIONS ARE PLEDGED, AFAR SPENDS DOWN PRIOR YEAR CONTRIBUTIONS. THIS GAAP REPORTING REQUIREMENT CAN CREATE LARGE POSITIVE AND NEGATIVE CHANGES IN TOTAL CONTRIBUTIONS (PART 1, LINE 8), REVENUE LESS EXPENSES (PART 1, LINE 19) AND NET ASSETS (PART 1, LINE 22). FORM 990, PART VI, SECTION A, LINE 2 THERE ARE TWO MARRIED COUPLES ON THE AFAR BOARD OF DIRECTORS - (1) RICHARD BESDINE AND TERRIE FOX WETLE AND (2) NIR AND LAURA BARZILAI. FORM 990, PART VI, SECTION A, LINE 4 AFAR ADOPTED NEW BY-LAWS ON 12/1/22. FORM 990, PART VI, SECTION B, LINE 11B AFAR'S FINANCE COMMITTEE PERFORMS THE INITIAL REVIEW OF THE DRAFT 990 DOCUMENT. THE FINANCE COMMITTEE REQUESTS CHANGES AS NEEDED AND APPROVES THE DOCUMENT. AFTER COMMITTEE APPROVAL HAS BEEN OBTAINED, THE MEMBERS OF THE AFAR BOARD OF DIRECTORS ARE PROVIDED WITH A COPY OF THE FINAL VERSION OF THE FORM 990. THE EXECUTIVE DIRECTOR THEN SIGNS THE DOCUMENT FOR FILING WITH THE APPROPRIATE AGENCY. FORM 990, PART VI, SECTION B, LINE 12C AT THE BEGINNING OF EACH FISCAL YEAR, AFAR DIRECTORS ARE SENT A COPY OF THE ORGANIZATION'S CONFLICT OF INTEREST POLICY FOR THEIR REVIEW AND SIGNATURE. DIRECTORS RETURN THE EXECUTED COPIES TO THE ORGANIZATION. DIRECTORS ARE ALSO ASKED TO INFORM THE BOARD CHAIR AND EXECUTIVE DIRECTOR OF ANY POSSIBLE CONFLICTS OF INTEREST THAT ARISE DURING THE COURSE OF THE YEAR. EACH CASE REPORTED IS EVALUATED SEPARATELY AND AN APPROPRIATE DETERMINATION/RESOLUTION IS REACHED. FORM 990, PART VI, SECTION B, LINE 15 THE ORGANIZATION'S BOARD OF DIRECTORS HAS A COMPENSATION ANALYSIS TASK FORCE THAT IS EMPOWERED TO PERIODICALLY REVIEW THE COMPENSATION OF THE CHIEF EXECUTIVE (EXECUTIVE DIRECTOR) OF THE ORGANIZATION AND THE DEPUTY EXECUTIVE (DEPUTY EXECUTIVE DIRECTOR). THE PROCESS INCLUDES A REVIEW OF THE COMPENSATION OF EXECUTIVE DIRECTORS AND SIMILAR POSITIONS AT LIKE-MINDED ORGANIZATIONS, REVIEW OF RECENT NOT-FOR-PROFIT COMPENSATION SURVEYS AND CLOSED SESSION DISCUSSIONS ON THE RECENT OVERALL PERFORMANCE OF THE EXECUTIVE DIRECTOR AND THE DEPUTY EXECUTIVE DIRECTOR. THE COMPENSATION ANALYSIS TASKFORCE IN CONJUNCTION WITH BOARD CHAIR FIXES THE COMPENSATION OF THE EXECUTIVE DIRECTOR AND THE DEPUTY EXECUTIVE DIRECTOR. FORM 990, PART VI, SECTION C, LINE 18 THE ORGANIZATION'S 990 IS POSTED ON THE AFAR WEBSITE AND IS PROVIDED TO GUIDESTAR AND CHARITY NAVIGATOR WHO MAY POST IT ONLINE. FORM 990, PART VI, SECTION C, LINE 19 THE GOVERNING DOCUMENTS OF THE ORGANIZATION ARE AVAILABLE FOR INSPECTION BY THE PUBLIC UPON REQUEST IN ELECTRONIC OR HARD COPY FORMAT. THE ORGANIZATION'S CONFLICT OF INTEREST, WHISTLEBLOWER AND DOCUMENT RETENTION POLICIES ARE AVAILABLE UPON REQUEST FOR INSPECTION BY THE PUBLIC IN ELECTRONIC OR HARD COPY FORMAT. THE ORGANIZATION'S FINANCIAL STATEMENTS ARE AVAILABLE ON AFAR'S WEBSITE. FORM 990, PART XI, LINE 9: CHANGES IN BENEFICIAL INTEREST IN CHARITABLE REMAINDER TRUST -428,958. GRANT REFUNDS AND WRITE OFFS 299,494. FORM 990, PAGE 12, PART XII, LINE 2C: THE ORGANIZATION HAS A COMMITTEE THAT ASSUMES RESPONSIBILITY FOR OVERSIGHT OF THE AUDIT OF ITS FINANCIAL STATEMENTS. FOR THE YEAR ENDED 12/31/22, THE ORGANIZATION HAS NOT CHANGED ITS SELECTION OF AN INDEPENDENT AUDITOR.